Elaine Lo is a pharmacist who is specialized in Ambulatory Care in Dallas, Texas. Patients can reach her at 4500 S Lancaster Rd, Dallas or contact her on 214-742-8387. Active license number of Elaine Lo is 56873 for Ambulatory Care in Texas. Elaine Lo is a licensed pharmacist who has demonstrated specialized knowledge and skill in the provision of integrated, accessible health care services by pharmacists and is accountable for addressing medication needs, developing sustained partnerships with patients, and practicing in the context of family and community.
Complete Profile:
Elaine Lo speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Elaine Lo
Specialization:
Ambulatory Care
Credentials:
PHARM.D.
Gender:
Female
Location:
4500 S Lancaster Rd, Dallas, Texas, 75216-7167
Phone:
214-742-8387
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Elaine Lo are as mentioned below.
NPI Number:
1669928404
NPI Enumeration Date:
31 Aug, 2016
NPI Last Update On:
31 Aug, 2016
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Elaine Lo are as mentioned below.
Specialization
License Number
State
Status
Ambulatory Care
56873
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
4500 S Lancaster Rd, Dallas, Texas
Zip:
75216-7167
Phone Number:
--
Fax Number:
--
Patients can reach Elaine Lo at 4500 S Lancaster Rd, Dallas, Texas or can call on phone at 214-742-8387.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.